Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL)

Daniela V. Wenge, Klaus Wethmar, Corinna Klar, Hedwig Kolve, Tim Sauer, Linus Angenendt, Georg Evers, Simon Call, Andrea Kerkhoff, Cyrus Khandanpour, Torsten Kessler, Rolf M. Mesters, Christoph Schliemann, Jan-Henrik Mikesch, Christian Reicherts, Monika Brüggemann, Wolfgang E. Berdel, Georg Lenz, Matthias Stelljes

Blood (2021) 138 (Supplement 1): 3365.

https://doi.org/10.1182/blood-2021-146459

Published: 2021

Journal Articles

Impact of SERPINC1, PROC and PROS1 Mutations on the Thrombotic Phenotype in Children with Venous Thromboembolism: An Observational Multicenter Cohort Study

Verena Limperger, Gili Kenet, MD, Christine Heller, MD, Karin Kurnik, Ralf Knoefler, Rolf M Mesters, MD, Susan Halimeh, MD, Ulrike Nowak-Göttl

Blood (2014) 124 (21): 583.

https://doi.org/10.1182/blood.V124.21.583.583

Published: 2014

Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD

Blood (2014) 124 (21): 980.

https://doi.org/10.1182/blood.V124.21.980.980

Published: 2014

Journal Articles

Acute Myeloid Leukemia: The Outcome Is Determined By Age, Genetic Group, White Blood Cell Count, Lactate Dehydrogenase, Rather Than By Chemotherapy Intensity

Blood (2013) 122 (21): 1447.

https://doi.org/10.1182/blood.V122.21.1447.1447

Published: 2013

Journal Articles

Targeting Interleukin-2 to the Neovasculature Potentiates Rituximab‘s Activity Against Mantle Cell Lymphoma in Mice

Christoph Schliemann, MD, Niklas Börschel, Christian Schwöppe, PhD, Rüdiger Liersch, MD, Torsten Kessler, MD, Martin Dreyling, Wolfram Klapper, MD, Hans D. Menssen, MD, Dario Neri, PhD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD

Blood (2012) 120 (21): 3716.

https://doi.org/10.1182/blood.V120.21.3716.3716

Published: 2012

Journal Articles

Long-Term Prophylaxis In Children, Adolescents and Young Adults with Von Willebrand Disease – First Results of a Cohort Study

Susan Halimeh, MD, Anne Kruempel, Hannelore Rott, Nadja Bogdanova, Ulrich Budde, MD, Daniela Manner, Britta Faeser, Rolf M. Mesters, Ulrike Nowak-Gottl, MD

Blood (2010) 116 (21): 714.

https://doi.org/10.1182/blood.V116.21.714.714

Published: 2010

Journal Articles

Impact of Reduced Von Willebrand Factor-Cleaving Protease [ADAMTS13] In Pediatric Stroke: A Nested Case-Control Study

Ulrike Nowak-Gottl, MD, Moritz Lambers, Sabine Thedieck, Daniela Manner, MD, Rolf M. Mesters, Ralf Junker, MD, Monika Stoll, PhD

Blood (2010) 116 (21): 805.

https://doi.org/10.1182/blood.V116.21.805.805

Published: 2010

Journal Articles

Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Gili Kenet, MD, Mariana Bonduel, Anthony Chan, MBBS, FRCPC, FRCPath, Neil Goldenberg, Suzzane Holtzhauer, Alfonso Iorio, Janna M. Journeycake, MD, Ralf Junker, Christoph Male, Mary Patricia Massicotte, MD, Rolf M. Mesters, Paul Monagle, MBBS, MD, MSc, Heleen Van Ommen, Leslie Raffini, MD, Paolo Simioni, Guy Young, MD, Ulrike Nowak-Gottl, MD

Blood (2010) 116 (21): 3169.

https://doi.org/10.1182/blood.V116.21.3169.3169

Published: 2010

Journal Articles

Induction Therapy by Ara-C Plus Daunorubicin Versus Ara-C Plus Gemtuzumab Ozogamicin: Interim Analysis of a Randomized Phase II Trial of the SAL In Elderly Patients with Acute Myeloid Leukemia

Uta Brunnberg, Michael Mohr, Richard Noppeney, Heinz A. Duerk, Maria Cristina Sauerland, Carsten Müller-Tidow, Utz O Krug, Steffen Koschmieder, Torsten Kessler, Rolf M. Mesters, Christiane Schulz, Thomas Buchner, Gerhard Ehninger, Ulrich Dührsen, Hubert Serve, Wolfgang E. Berdel

Blood (2010) 116 (21): 335.

https://doi.org/10.1182/blood.V116.21.335.335

Published: 2010

Journal Articles

Response: NGR and isoDGR are separate moieties binding to different receptors

Christian Schwöppe, Ralf Bieker, Rolf M. Mesters, Wolfgang E. Berdel

Blood (2009) 113 (21): 5367.

https://doi.org/10.1182/blood-2009-03-208884

Published: 2009

Journal Articles

Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience

Ralf Bieker, Torsten Kessler, Christian Schwöppe, Teresa Padró, Thorsten Persigehl, Christoph Bremer, Johannes Dreischalück, Astrid Kolkmeyer, Walter Heindel, Rolf M. Mesters, Wolfgang E. Berdel

Blood (2009) 113 (20): 5019–5027.

https://doi.org/10.1182/blood-2008-04-150318

Published: 2009

Journal Articles

Use of Palifermin for the Prevention of High-Dose Methotrexate-Induced Oral Mucositis.

Eva Schmidt, MD, Nils H. Thoennissen, M.D., Annika Rudat, M.D., Ralf Bieker, M.D., Christoph Schliemann, M.D., Rolf M. Mesters, M.D., Michael Zühlsdorf, M.D., Carsten Müller-Tidow, M.D., Wolfgang E. Berdel, M.D.

Blood (2007) 110 (11): 4445.

https://doi.org/10.1182/blood.V110.11.4445.4445

Published: 2007

Journal Articles

Expression of Angiopoietins and Their Receptor Tie2 in the Bone Marrow of Patients with Acute Myeloid Leukemia.

Christoph Schliemann, MD, Ralf Bieker, MD, Teresa Padro, MD, Torsten Kessler, MD, Heike Hintelmann, Thomas Buchner, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD

Blood (2006) 108 (11): 1894.

https://doi.org/10.1182/blood.V108.11.1894.1894

Published: 2006

Journal Articles

Bevacizumab Reduces VEGF Expression in Patients with Relapsed and/or Refractory Acute Myeloid Leukaemia (AML) without Clinical Antileukemic Activity.

Lejla Zahiragic, MD, Christoph Schliemann, MD, Ralf Bieker, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD

Blood (2006) 108 (11): 4543.

https://doi.org/10.1182/blood.V108.11.4543.4543

Published: 2006

Journal Articles

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups

Guido Bisping, Martin Kropff, Doris Wenning, Britta Dreyer, Sergey Bessonov, Frank Hilberg, Gerald J. Roth, Gerd Munzert, Martin Stefanic, Matthias Stelljes, Christian Scheffold, Carsten Müller-Tidow, Peter Liebisch, Nicola Lang, Jöelle Tchinda, Hubert L. Serve, Rolf M. Mesters, Wolfgang E. Berdel, Joachim Kienast

Blood (2006) 107 (5): 2079–2089.

https://doi.org/10.1182/blood-2004-11-4250

Published: 2006

Journal Articles

Inhibition of Tumor Growth by RGD Peptide Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature.

Torsten Kessler, MD, Ralf Bieker, MD, Teresa Padro, PhD, Federico Herrera, MD, Sandra Ruiz, MD, Hubert Serve, MD, Micheal Kreuter, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD

Blood (2004) 104 (11): 1934.

https://doi.org/10.1182/blood.V104.11.1934.1934

Published: 2004

Journal Articles

Prothrombin Residues 473 to 487 Contribute To Factor Va Binding in the Prothrombinase Complex.

Subramanian Yegneswaran, Ph.D., Rolf M. Mesters, M.D., Jose A. Fernandez, M.D. Ph.D., John H. Griffin, Ph.D.

Blood (2004) 104 (11): 1720.

https://doi.org/10.1182/blood.V104.11.1720.1720

Published: 2004

Journal Articles

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma

Guido Bisping, Regine Leo, Doris Wenning, Berno Dankbar, Teresa Padró, Martin Kropff, Christian Scheffold, Matthias Kröger, Rolf M. Mesters, Wolfgang E. Berdel, Joachim Kienast

Blood (2003) 101 (7): 2775–2783.

https://doi.org/10.1182/blood-2002-09-2907

Published: 2003

Journal Articles

Efficacy and safety of thalidomide in patients with acute myeloid leukemia

Martin B. Steins, Teresa Padró, Ralf Bieker, Sandra Ruiz, Martin Kropff, Joachim Kienast, Torsten Kessler, Thomas Buechner, Wolfgang E. Berdel, Rolf M. Mesters

Blood (2002) 99 (3): 834–839.

https://doi.org/10.1182/blood.V99.3.834

Published: 2002

Journal Articles

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia

Rolf M. Mesters, Teresa Padró, Ralf Bieker, Martin Steins, Michael Kreuter, Michael Göner, Stephen Kelsey, Paul Scigalla, Walter Fiedler, Thomas Büchner, Wolfgang E. Berdel

Blood (2001) 98 (1): 241–243.

https://doi.org/10.1182/blood.V98.1.241

Published: 2001

NARROW

Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL)

Impact of SERPINC1, PROC and PROS1 Mutations on the Thrombotic Phenotype in Children with Venous Thromboembolism: An Observational Multicenter Cohort Study

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia: The Outcome Is Determined By Age, Genetic Group, White Blood Cell Count, Lactate Dehydrogenase, Rather Than By Chemotherapy Intensity

Targeting Interleukin-2 to the Neovasculature Potentiates Rituximab‘s Activity Against Mantle Cell Lymphoma in Mice

Long-Term Prophylaxis In Children, Adolescents and Young Adults with Von Willebrand Disease – First Results of a Cohort Study

Impact of Reduced Von Willebrand Factor-Cleaving Protease [ADAMTS13] In Pediatric Stroke: A Nested Case-Control Study

Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Induction Therapy by Ara-C Plus Daunorubicin Versus Ara-C Plus Gemtuzumab Ozogamicin: Interim Analysis of a Randomized Phase II Trial of the SAL In Elderly Patients with Acute Myeloid Leukemia

Response: NGR and isoDGR are separate moieties binding to different receptors

Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience

Use of Palifermin for the Prevention of High-Dose Methotrexate-Induced Oral Mucositis.

Expression of Angiopoietins and Their Receptor Tie2 in the Bone Marrow of Patients with Acute Myeloid Leukemia.

Bevacizumab Reduces VEGF Expression in Patients with Relapsed and/or Refractory Acute Myeloid Leukaemia (AML) without Clinical Antileukemic Activity.

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups

Inhibition of Tumor Growth by RGD Peptide Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature.

Prothrombin Residues 473 to 487 Contribute To Factor Va Binding in the Prothrombinase Complex.

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma

Efficacy and safety of thalidomide in patients with acute myeloid leukemia

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only